Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2005

Cioc AM, Frambach GE, Magro CM. Light-chain-restricted plasmacellular infiltrates in necrobiosis lipoidica -- a clue to an underlying monoclonal gammopathy. J Cutan Pathol. 2005;32(4):263-7.

Magro C, Ali N, Williams JA, Allen JN, Ross P. Cytomegalovirus-associated pulmonary septal capillary injury sine inclusion body change: a distinctive cause of occult or macroscopic pulmonary hemorrhage in the immunocompetent host. Appl Immunohistochem Mol Morphol. 2005;13(3):268-72.

Sanchez T, Thangada S, Wu M-, Kontos CD, Wu D, Wu H, et al. PTEN as an effector in the signaling of antimigratory G protein-coupled receptor. Proc Natl Acad Sci U S A. 2005;102(12):4312-7.

Neelapu SS, Gause BL, Nikcevich DA, Schuster SJ, Winter J, Gockerman JP, et al. Phase III randomized trial of patient-specific vaccination for previously untreated patients with follicular lymphoma in first complete remission: protocol summary and interim report. Clin Lymphoma. 2005;6(1):61-4.

Verma S, Frambach GE, Seilstad KH, Nuovo G, Porcu P, Magro CM. Epstein--Barr virus-associated B-cell lymphoma in the setting of iatrogenic immune dysregulation presenting initially in the skin. J Cutan Pathol. 2005;32(7):474-83.

Hecht JL, Ince TA, Baak JP, Baker HE, Ogden MW, Mutter GL. Prediction of endometrial carcinoma by subjective endometrial intraepithelial neoplasia diagnosis. Mod Pathol. 2005;18(3):324-30.

Ely S, Di Liberto M, Niesvizky R, Baughn LB, Cho HJ, Hatada EN, et al. Mutually exclusive cyclin-dependent kinase 4/cyclin D1 and cyclin-dependent kinase 6/cyclin D2 pairing inactivates retinoblastoma protein and promotes cell cycle dysregulation in multiple myeloma. Cancer Res. 2005;65(24):11345-53.

Sboner A, Aliferis CF. Modeling clinical judgment and implicit guideline compliance in the diagnosis of melanomas using machine learning. AMIA Annu Symp Proc. 2005:664-8.

Ross P, Magro CM. Clonal light chain restricted primary intrapulmonary nodular amyloidosis. Ann Thorac Surg. 2005;80(1):344-7.

Gu Z, Rubin MA, Yang Y, Deprimo SE, Zhao H, Horvath S, et al. Reg IV: a promising marker of hormone refractory metastatic prostate cancer. Clin Cancer Res. 2005;11(6):2237-43.